Stock Scorecard



Stock Summary for Orthofix Medical Inc (OFIX) - $10.96 as of 7/24/2026 11:27:45 AM EST

Total Score

9 out of 30

Safety Score

21 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for OFIX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for OFIX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for OFIX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for OFIX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for OFIX (21 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 2
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for OFIX

Orthofix Medical Inc (OFIX) Shareholder Structure: Major Shareholders & Institutional Holdings 7/25/2026 7:43:00 AM
Orthofix Medical Inc (OFIX) Financial Health: Profitability & Balance Sheet Analysis 7/25/2026 4:43:00 AM
Orthofix Medical Inc. (OFIX) stock price, news, quote and history 7/25/2026 12:41:00 AM
OFIX|Orthofix Medical Inc|Price:11.260|Chg%:+0.300 7/24/2026 8:40:00 PM
Orthofix Medical Inc. (OFIX) stock price, news, quote and history 7/24/2026 7:40:00 AM
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement 7/23/2026 4:09:00 PM
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth 7/21/2026 11:40:00 PM
Press Release: Orthofix to Report Second Quarter 2026 Financial Results 7/15/2026 3:10:00 PM
Price to sales forward of Orthofix Medical Inc. – NASDAQ:OFIX 7/10/2026 4:10:00 PM
Orthofix Medical | 4: Statement of changes in beneficial ownership of securities-Director Hannon Jason 7/8/2026 7:14:00 PM

Financial Details for OFIX

Company Overview

Ticker OFIX
Company Name Orthofix Medical Inc
Country N/A
Description Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is headquartered in Lewisville, Texas.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 3/31/2026
Next Earnings Date 8/5/2026

Stock Price History

Last Day Price 10.96
Price 4 Years Ago 20.53
Last Day Price Updated 7/24/2026 11:27:45 AM EST
Last Day Volume 181,372
Average Daily Volume 385,795
52-Week High 16.99
52-Week Low 8.85
Last Price to 52 Week Low 23.84%

Valuation Measures

Trailing PE N/A
Industry PE 86.00
Sector PE 88.41
5-Year Average PE 46.94
Free Cash Flow Ratio 3.68
Industry Free Cash Flow Ratio 26.13
Sector Free Cash Flow Ratio 29.81
Current Ratio Most Recent Quarter 2.87
Total Cash Per Share 2.98
Book Value Per Share Most Recent Quarter 10.78
Price to Book Ratio 1.08
Industry Price to Book Ratio 4.97
Sector Price to Book Ratio 11.88
Price to Sales Ratio Twelve Trailing Months 0.57
Industry Price to Sales Ratio Twelve Trailing Months 3.97
Sector Price to Sales Ratio Twelve Trailing Months 4.99
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 40,421,700
Market Capitalization 443,021,832
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 10.80%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 26.83%
Reported EPS 12 Trailing Months -1.50
Reported EPS Past Year -0.11
Reported EPS Prior Year 0.54
Net Income Twelve Trailing Months -60,006,000
Net Income Past Year -92,192,000
Net Income Prior Year -125,997,000
Quarterly Revenue Growth YOY 1.60%
5-Year Revenue Growth 15.13%
Operating Margin Twelve Trailing Months -6.75%

Balance Sheet

Total Cash Most Recent Quarter 120,278,000
Total Cash Past Year 82,025,000
Total Cash Prior Year 83,238,000
Net Cash Position Most Recent Quarter -101,057,000
Net Cash Position Past Year -75,366,000
Long Term Debt Past Year 157,391,000
Long Term Debt Prior Year 157,015,000
Total Debt Most Recent Quarter 221,335,000
Equity to Debt Ratio Past Year 0.74
Equity to Debt Ratio Most Recent Quarter 0.66
Total Stockholder Equity Past Year 450,037,000
Total Stockholder Equity Prior Year 503,124,000
Total Stockholder Equity Most Recent Quarter 435,186,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -3,629,090
Free Cash Flow Per Share Twelve Trailing Months -0.09
Free Cash Flow Past Year -1,279,000
Free Cash Flow Prior Year -9,086,000

Options

Put/Call Ratio 6.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.35
MACD Signal 0.32
20-Day Bollinger Lower Band 9.01
20-Day Bollinger Middle Band 11.12
20-Day Bollinger Upper Band 13.23
Beta 0.71
RSI 50.86
50-Day SMA 13.25
150-Day SMA 14.03
200-Day SMA 15.25

System

Modified 7/25/2026 12:29:08 AM EST